Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data.
Matthias ZunhammerTamás SpisákTor D WagerUlrike Bingelnull nullPublished in: Nature communications (2021)
The brain systems underlying placebo analgesia are insufficiently understood. Here we performed a systematic, participant-level meta-analysis of experimental functional neuroimaging studies of evoked pain under stimulus-intensity-matched placebo and control conditions, encompassing 603 healthy participants from 20 (out of 28 eligible) studies. We find that placebo vs. control treatments induce small, widespread reductions in pain-related activity, particularly in regions belonging to ventral attention (including mid-insula) and somatomotor networks (including posterior insula). Behavioral placebo analgesia correlates with reduced pain-related activity in these networks and the thalamus, habenula, mid-cingulate, and supplementary motor area. Placebo-associated activity increases occur mainly in frontoparietal regions, with high between-study heterogeneity. We conclude that placebo treatments affect pain-related activity in multiple brain areas, which may reflect changes in nociception and/or other affective and decision-making processes surrounding pain. Between-study heterogeneity suggests that placebo analgesia is a multi-faceted phenomenon involving multiple cerebral mechanisms that differ across studies.
Keyphrases
- pain management
- chronic pain
- double blind
- functional connectivity
- phase iii
- resting state
- postoperative pain
- neuropathic pain
- systematic review
- placebo controlled
- case control
- decision making
- ultrasound guided
- randomized controlled trial
- white matter
- single cell
- bipolar disorder
- deep brain stimulation
- multiple sclerosis
- machine learning
- cerebral ischemia
- artificial intelligence
- big data
- data analysis